Fox Chase Cancer Center Scientist Receives Award from Leukemia and Lymphoma Society
PHILADELPHIA (April 5, 2002) -- Valery Sudakin, Ph.D., a scientist at Fox Chase Cancer Center in Philadelphia, has been awarded a three-year Special Fellowship by the Leukemia and Lymphoma Society for his work in cell cycle regulation. Dr. Sudakin has been working in the cell biology laboratory at Fox Chase Cancer Center since 1997.
"We are very excited for Valery," said Timothy Yen, Ph.D. senior member at Fox Chase. "This award is a reflection of his focus and dedication to his research initiatives," he said. "I am particularly pleased that the Leukemia and Lymphoma Society has maintained their longstanding commitment to support basic research," Dr. Yen added.
"I am honored to receive this award," said Dr. Sudakin. "This will allow me to continue my research into understanding the mechanisms of cell division and why some discrepancies in cell cycle regulation cause chromosome instability that can lead to cancer."
Dr. Sudakin's work addresses the fundamental question of how human cells accurately distribute their 23 pairs of chromosomes during mitosis or cell division. Mistakes along any step of these complex biological processes can lead to birth and developmental defects, cancer and resistance to anti-cancer drugs.
During mitosis or cell division, all chromosomes must be positioned at the center of the cell before the cell can divide. If cells divide before all their chromosomes are aligned, the resultant daughter cells will not contain the same number of chromosomes and become aneuploid, a hallmark of many types of cancers including leukemia. Dr. Sudakin's research may also provide new strategies that can more effectively kill tumors.
A native of Kiev, Ukraine, Sudakin received his Ph.D. from Technion-Israel Institute of Technology in Haifa, Israel before coming to Fox Chase Cancer Center. Sudakin has been the recipient of past fellowships including a Fulbright Postdoctoral award in 1997, and a Human Frontier Long-Term fellowship award in 1998. He has authored many studies - one most recently published in The Journal of Cell Biology - and was an invited speaker for the past few years at the Annual Meeting of the American Society for Cell Biology. He resides in the Bustleton section of Northeast Philadelphia with his wife and daughter.
Fox Chase Cancer Center, one of the nation's first comprehensive cancer centers designated by the National Cancer Institute in 1974, conducts basic and clinical research; programs of prevention, detection and treatment of cancer; and community outreach. For more information about Fox Chase activities, visit the Center's web site at www.fccc.edu.
Fox Chase Cancer Center, part of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence four consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. For more information, call 1-888-FOX CHASE or (1-888-369-2427).
Media inquiries only, please contact Jeremy Moore at 215-728-2700.